Health
Nivolumab and Chemotherapy for Mesothelioma is Focus of New Trial – Surviving Mesothelioma
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients after surgery.
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients who have had surgery.
Nivolumab (Opdivo) is an immunotherapy drug similar to pembrolizumab (Keytruda). It blocks a protein that helps mesothelioma cells hide from the immune system. Nivolumab is most often used for patients with non-small cell lung cancer.
The multicenter German study will test if a combination of nivolumab and chemotherapy can help keep tumors from growing…
-
Noosa News23 hours agoPill checking to resume in Queensland months after government axed funding
-
Noosa News21 hours agoQueensland girl Millie’s fight for life after magnets tore through her bowel
-
Noosa News11 hours agoSee inside the hidden suburbs where Queensland investors really live
-
Noosa News21 hours agoMother who faked daughter’s medical conditions, forged documents, granted immediate parole